**Elevated mosquito activity and a sharp rise in confirmed West Nile neuroinvasive disease (WNND) cases are the main drivers positioning the 35–49 range as the market leader at 48.5% implied probability.** As of early October 2026, New York City has recorded 31 WNND cases—already exceeding the full-year 2025 total of 16 and the 2021–2025 average of 25—alongside 6 milder West Nile fever cases and a record 1,772 positive mosquito pools, up from 1,378 the prior year. Warmer conditions have extended mosquito breeding and amplified Culex vector populations citywide, with Brooklyn, Queens, and Staten Island showing the highest case loads. WNND, which involves encephalitis, meningitis, or acute flaccid paralysis, is reported more reliably than mild infections because it requires hospitalization; only about 1 in 150 infections progress to this severe form, mainly among adults over 60 or those with comorbidities. The season typically peaks in August–September and tapers by late October, so final 2026 totals will depend on remaining surveillance updates from the NYC Health Department. Traders appear to weigh the strong ongoing transmission signal and historical precedent (recent highs of 36 cases) against the chance of a late-season slowdown, keeping the 20–34 bin as a secondary outcome while assigning low odds to extremes below 20 or 50+.